Literature DB >> 24154554

Recurrent extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection due to an infected intrauterine device.

Chee-Kin Hui.   

Abstract

The use of intrauterine devices (IUDs) have been widespread since the 1960s. In 2002, the World Health Organization estimated that approximately 160 million women worldwide use IUDs. However, IUDs are associated with short-term complications such as vaginal bleeding, pelvic discomfort, dyspareunia and pelvic infection. Herein, we report the case of a woman who had recurrent urinary tract infection (UTI) due to the use of an IUD, even after treatment. The patient developed four episodes of UTI within a seven-month period after IUD insertion. During each episode of UTI, extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) was cultured from the patient’s midstream urine. The IUD was finally removed, and culture of the removed IUD was positive for ESBL-producing E. coli. An infected IUD as a source of recurrent UTI should be considered in women with IUD in situ who develop recurrent UTI even after treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24154554      PMCID: PMC4291936          DOI: 10.11622/smedj.2013213

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  11 in total

1.  Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?

Authors:  Mira Harrison-Woolrych; Janelle Ashton; David Coulter
Journal:  Contraception       Date:  2003-01       Impact factor: 3.375

Review 2.  Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.

Authors:  Anshu P Mohllajee; Kathryn M Curtis; Herbert B Peterson
Journal:  Contraception       Date:  2005-10-19       Impact factor: 3.375

3.  Effects of contraceptive pills and intrauterine devices on urinary bladder.

Authors:  M M Zahran; M I Osman; M Kamel; M Fayad; H Mooro; A F Youssef
Journal:  Urology       Date:  1976-12       Impact factor: 2.649

4.  The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.

Authors:  K M Elhag; A M Bahar; A A Mubarak
Journal:  J Med Microbiol       Date:  1988-04       Impact factor: 2.472

Review 5.  Intrauterine device and upper-genital-tract infection.

Authors:  D A Grimes
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

6.  Actinomycosis infection associated with intrauterine contraceptive devices.

Authors:  C Keebler; A Chatwani; R Schwartz
Journal:  Am J Obstet Gynecol       Date:  1983-03-01       Impact factor: 8.661

7.  The relationship of genital tract actinomycetes and the development of pelvic inflammatory disease.

Authors:  R Burkman; S Schlesselman; L McCaffrey; P K Gupta; M Spence
Journal:  Am J Obstet Gynecol       Date:  1982-07-01       Impact factor: 8.661

Review 8.  Intrauterine devices - upper and lower genital tract infections.

Authors:  Olav Meirik
Journal:  Contraception       Date:  2007-02-16       Impact factor: 3.375

9.  Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess.

Authors:  Georgios Charonis; Per-Göran Larsson
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

10.  Asymptomatic bacteriuria in users of intrauterine devices.

Authors:  Masoumeh Fallahian; Esmat Mashhady; Zohreh Amiri
Journal:  Urol J       Date:  2005       Impact factor: 1.510

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.